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Background. The prevalence of depression in rural Ugandan communities is high and yet detection and treatment of
depression in the primary care setting is suboptimal. Short valid depression screening measures may improve detection
of depression. We describe the validation of the Luganda translated nine- and two-item Patient Health Questionnaires
(PHQ-9 and PHQ-2) as screening tools for depression in two rural primary care facilities in Eastern Uganda.
Methods. A total of 1407 adult respondents were screened consecutively using the nine-item Luganda PHQ. Of these
212 were randomly selected to respond to the Mini International Neuropsychiatric Interview diagnostic questionnaire.
Descriptive statistics for respondents’ demographic characteristics and PHQ scores were generated. The sensitivity, spe-
ciﬁcity and positive predictive values (PPVs), and area under the ROC curve were determined for both the PHQ-9 and
PHQ-2.
Results. The optimum trade-oﬀ between sensitivity and PPV was at a cut-oﬀ of ≧5. The weighted area under the re-
ceiver Operating Characteristic curve was 0.74 (95% CI 0.60–0.89) and 0.68 (95% CI 0.54–0.82) for PHQ-9 and PHQ-2,
respectively.
Conclusion. The Luganda translation of the PHQ-9 was found to be modestly useful in detecting depression. The PHQ-
9 performed only slightly better than the PHQ-2 in this rural Ugandan Primary care setting. Future research could im-
prove on diagnostic accuracy by considering the idioms of distress among Luganda speakers, and revising the PHQ-9
accordingly. The usefulness of the PHQ-2 in this rural population should be viewed with caution.
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Background
Depression is common, chronic and costly for both suf-
ferers and health care systems. It is estimated to be a
leading cause of disability worldwide but data on
population rates of depression in developing countries
remain sparse (Whiteford et al. 2013). Two surveys
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conducted among adults living in rural areas of
Uganda found the point prevalence of major depres-
sion to be between 17% and 24% (Bolton et al. 2003;
Ovuga et al. 2005).
Despite the high burden and substantial impact of
depression, detection and treatment in the primary
care setting are suboptimal. In high-income countries,
primary care physicians fail to recognize 30%–50% of
depressed patients (Simon & VonKorﬀ, 1995). This
diagnosis gap is estimated to be even more substantial
in low-income countries (Kohn et al. 2004; Wang et al.
2007).
Short valid depression screening measures such as
the nine-item Patient Health Questionnaire (PHQ-9)
(Kroenke et al. 2001) may help primary care health
workers identify patients with depressive symptoms
Pignone et al. (2002) in their systematic review of ran-
domized controlled studies of depression screening in
primary care settings showed that use of screening
instruments led to increased recognition of depression
in primary care in the USA.
The PHQ-9 has been validated in a variety of set-
tings worldwide (Wittkampf et al. 2007; Manea et al.
2012). In sub-Saharan Africa, validation studies have
been conducted among university students in Nigeria
(Adewuya et al. 2006) and postnatal women in
Ghana (Weobong et al. 2009). Studies have also been
conducted among people living with HIV in Kenya
(Monahan et al. 2009), Cameroon (Pence et al. 2012)
and in Uganda (Akena et al. 2013), where they found
an AUROC of 0.96. The PHQ-9 and two-item Patient
Health Questionnaire (PHQ-2) has been recently vali-
dated among general health facility attendees in
Ethiopia (Hanlon et al. 2015) and South Africa (Bhana
et al. 2015). However, no such study has yet been con-
ducted in Uganda. Understanding the diagnostic ac-
curacy and validity of the PHQ-9 is essential if the
PHQ-9 is going to be used as a screening tool to in-
crease detection of depression by non-mental health
professionals, improve opportunity for mental health
care and reduce the depression treatment gap in
Uganda.
This study therefore aims to conﬁrm the validity and
diagnostic accuracy of the Luganda PHQ-9, and of a
shortened version of the PHQ-9, the PHQ-2, in detect-
ing depression among an adult population attending
primary care clinics in rural Uganda. It also aims to
examine the internal structure of the translated tool.
Methods
Study setting
Kamuli District was selected for the integration of
mental health services for depression, alcohol use
disorder, psychosis and epilepsy into primary health
care sector as part of the Programme for Improving
Mental Health Care (PRIME) (Lund et al. 2012) in col-
laboration with the Uganda Ministry of Health
(Kigozi et al. 2016). Kamuli District has a population
of 490 000, of whom 96% reside in rural areas
(Uganda Bureau of Statistics, 2016). This population
is served by 41 primary health care centres and two
hospital outpatient departments. Primary care centres
in Kamuli provide ﬁrst level outpatient health care, in-
cluding treatment of acute infections, minor accidents,
maternal and child health services and basic mental
health assessments treatment and referral. Most
patients with depression or suicide will come to the
health centre or outpatient department of a hospital
with somatic complaints or physical consequences of
a suicide attempt, which may or may not trigger a psy-
chiatric assessment, treatment or referral. Up to 100
patients may be seen a day at the health centres, all
conditions put together. The district hospital’s out-
patient department operates like a primary care facility
as a ﬁrst point of contact for many patients in the hos-
pital’s catchment area. The district hospital outpatient
department sees two to three times the number of
patients seen at the lower health centres.
Participants
Research assistants recruited patients attending one
primary health and one hospital outpatient depart-
ment into the study between October and December
2014. Participants were eligible for the study if they
were at least 18 years of age, ﬂuent in Luganda, were
attending the clinic for primary care and were avail-
able for a 30 min interview. Participants were excluded
if they required acute medical care. Participants were
recruited into a convenience sample, dictated by the
availability of the research assistants to recruit the
next patient who arrived to the clinic waiting room.
Study procedures
Recruitment and screening was done by two research
assistants who were general nurses working in
Kamuli. They had a 2-day training in the PHQ-9 ad-
ministration and spoke both English and Luganda.
After assessing the patient for inclusion and exclusion
criteria, the research assistant explained the study’s
purpose and procedures in the local language to en-
sure that even those participants with low literacy
understood. Signed (or thumb printed) informed con-
sent was obtained from patients who consented to par-
ticipate in the study.
In a private examination room, the research assistant
collected demographic information from the partici-
pant, administered the Luganda version of the
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PHQ-9 on paper and calculated the total screening
score. The research assistant then selected a sealed en-
velope, inside of which contained pre-printed set of
instructions. The instructions randomly allocated parti-
cipants to either the Mini International Neuropsychi-
atric Interview (MINI) or no MINI interview, so that
a subsample of 200 participants would be referred to
the diagnostic interview. An example of such an in-
struction is: ‘is the total score X? If yes, send respond-
ent to MINI interview. If no, select the next person who
scores X to go to the MINI interview.’ The screened but
un-referred participants were immediately returned to
the waiting room to be managed by the clinic staﬀ.
The diagnostic interview was conducted within min-
utes of the PHQ-9 interview in a room adjacent to the
outpatient department. Both the participant and the
diagnostician were blind to the participant’s PHQ-9
screening score. The diagnosticians were mental health
practitioners (one psychiatric clinical oﬃcer and one
psychiatric nurse with a diploma in clinical medicine
and nursing, respectively) who were ﬂuent in
Luganda. The diagnosticians completed a 2-day train-
ing in the use of the depression module of the MINI
diagnostic interview.
After the diagnostic interview was completed the re-
search assistant brought the participants back to the
waiting room. However, patients who responded posi-
tively to the suicide question either on PHQ-9 or in the
diagnostic interview were taken directly to a primary
care health worker for further assessment and manage-
ment by the primary care worker who was informed
about the need to assess and manage for suicidality.
Assessments
Patient health questionnaire (PHQ-9)
The PHQ-9 is the nine-item depression scale of the
Patient Health Questionnaire (Spitzer et al. 1994).
The nine items of the PHQ-9 are based directly on
the nine diagnostic criteria for major depressive
disorder in the DSM-IV (American Psychiatric
Association, 1994). Each item is scored on a likert
scale with symptoms rated as 0 (not at all), 1 (several
days), 2 (more than half the days) and 3 (nearly
every day).The PHQ-2 is a two-item version of the
PHQ-9. It is scored in the same manner as the
PHQ-9. It is advantageous for use by general clinicians
in busy health care facilities.
The English version of the PHQ-9 was translated
into Luganda by two bilingual translators. This was
followed by evaluation of the translated tools by two
bilingual clinical Psychologists who were familiar
with the constructs in the tool in order to gain consen-
sus on the translation. The consensus version of the
questionnaire was then piloted in a small sample of
30 respondents in a small health facility that was not
the study facility before the start of the study. This
pilot served to ensure linguistic and idiomatic equiva-
lence and to identify any challenges respondents might
have with the translation. Any unclear Luganda terms
were modiﬁed to include terms that are more com-
monly used and understandable by the participants
in order to produce a ﬁnal PHQ-9 Luganda translation.
This modiﬁcation of Luganda terms did not funda-
mentally change the items of the PHQ-9. The
Luganda translation of the PHQ-9 is available in the
additional ﬁles of this manuscript.
Mini-International Neuropsychiatric Inter (MINI) –
Depression module
The depression module of the MINI was used as the
gold standard. The MINI is a structured diagnostic
interview designed for research and clinical practice
in psychiatric and primary care settings. The depres-
sion module of the MINI 5.0.0 (Sheehan et al., 1998)
is used to diagnose current major depressive disorder.
The MINI depression module was translated into
Luganda using the same process as for the PHQ-9
described above. This process included the initial
translation of the English version, building consensus
by bilingual mental health experts, piloting and modi-
ﬁcation of diﬃcult terms to produce a ﬁnal version.
There was no change in the core items of the MINI
questionnaire.
Sample size
Given constraints on the availability of diagnosticians,
a validation sample size of 200 diagnostic interviews
was ﬁxed. The anticipated distribution of PHQ-9 scores
came from a study previously conducted with adult
attendees in public clinics in Kamuli in 2013, which was
characterized by a right skew. Accordingly, in order to
refer 200 participants with balanced distribution of
PHQ-9 scores, 1300 participants needed to be screened
with 7% of participant with low (0–2) scores, 11% of par-
ticipants with medium (3–7) scores and 100% of partici-
pants with high (≥8) scores being referred to complete
the diagnostic interview. A balance of scores in the ana-
lysis dataset would allow for more precise estimates of
the sensitivity and speciﬁcity of the PHQ-9 and PHQ-2
at higher cut points.
Statistical methods
Descriptive statistics were used to describe the demo-
graphic characteristics of the participants, their
PHQ-9 scores and the distribution of PHQ-9 and
PHQ-2 scores in the sample. The factor structure of
the Luganda PHQ-9 was examined using principle
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components analysis with varimax rotation, a Scree
plot and the Kaiser test. The internal consistency of
the Luganda PHQ-9 was calculated using Cronbach’s
alpha. The correlation of each item of the PHQ-9 was
assessed against the sum of the other eight items (the
item-rest correlation).
Diagnostic validity of the PHQ-9 and the PHQ-2 was
then evaluated using the area under the receiver oper-
ating curve (AUROC). The area under the receiver op-
erating characteristic curve (AUROC) of the PHQ-9
and the PHQ-2 were estimated using the Somers’ D
with Harrell’s c statistic (Newson, 2002), which
allowed for estimation of the AUROC with probability
weights. The 95% conﬁdence intervals for the weighted
AUROCs were based on bootstrap distribution of the
AUROC estimation procedures, using 5000 repetitions
(Alonzo & Pepe, 2005).
Ethics
The study procedures were approved by the human
subject protections boards at Makerere University
(Kampala, Uganda) and the University of Cape Town
(South Africa).
Results
We obtained informed consent from 1415 patients of
which a total of 1407 were screened on the PHQ-9
from both the health centre and the district hospital
outpatient department. Eight participants could not
complete the PHQ-9 because they were in a hurry.
Nearly half (48.3%) of participants had a low PHQ-9
score (0–2), a similar proportion (41.7%) had a medium
score (5–7) and 10.0% had a high score (8 and above).
A total of 212 (15.1% of 1407) participants were referred
to theMINIdiagnostic interview, ofwhom153 (72.2%of
212) completed the diagnostic interview. The rest with-
drew their participation due to time constraints. The
ﬂowdiagramof participants’ screening scores and refer-
ral to the MINI diagnostic is shown in Fig. 1.
Demographic and clinical characteristics of the
sample
In the total sample, the participants’ mean age was 32.6
years (S.D. 12.6, range 18–82) and 72.3% were female.
Of the female respondents, 17.5% were in the perinatal
period (deﬁned as being pregnant or having delivered
in the past 12 months). Nearly half (48.0%) of partici-
pants had completed primary school, while another
31.2% completed secondary school and 7.2% had com-
pleted some higher education. Many participants
(43.6%) were unemployed, while 42.7% were engaged
in paid or self-employment. Another 9.1% of partici-
pants were students.
The median PHQ-9 score was 3 [interquartile range
(IQR) 1–5, range 0–25] and the median PHQ-2 score
was 1 (IQR 0–2, range 0–6).
Among the 153 participants who completed the
MINI diagnostic interview, 84 (57%) were found to
have major depressive disorder. Seven per cent (103
of 1407) of participants reported having thoughts
about suicide or self-harm on PHQ-9 item no. 9.
Psychometric properties of the PHQ-9
Two analysis techniques showed two diﬀerent factor
structures of the PHQ-9. The Scree plot after varimax
rotation of Principal Component Analysis suggested
a two-factor solution (total variance explained = 43%)
while the Kaiser criteria suggested a three-factor solu-
tion (total variance explained = 57%). With three fac-
tors, PHQ items no. 2, 3 and 5 load onto factor 1,
PHQ items no. 6, 8 and 9 onto factor 2 and PHQ
items no. 1, 4 and 7 onto factor 3. Evidence of a multi-
factor solution precludes a coherent interpretation of
the Cronbach’s alpha for the internal consistency of
the PHQ-9, which was 0.68. The item-rest correlations
were all below 0.5: item no. 6 had the highest correl-
ation (0.48), while the lowest correlations were for
item no. 1 (0.19) and item no. 4 (0.23).
Validation of the PHQ-9 and PHQ-2
The weighted area under the receiver Operating
Characteristic curve for the PHQ-9 was 0.74 (95% CI
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0.60–0.89) and for the PHQ-2 was 0.68 (95% CI 0.54–
0.82) (Fig. 2).
Table 1 below shows the speciﬁcity, sensitivity and
positive predictive values (PPVs) of the PHQ-9 and
PHQ-2 at diﬀerent cut-oﬀ scores. In this study, the op-
timum trade-oﬀ between sensitivity and PPV was at a
cut-oﬀ of ≧5. It means therefore that at this cut-oﬀ, 67%
of people with depression are screen positive, 78% of
people without depression are screen negative, and
52% of screen positive people have depression. On
the PHQ-2, at a cut-of ≧1, 66% of people with depres-
sion are screen positive, 59% of people without depres-
sion are screen negative and 36% of people who are
screen positive have depression.
Discussion
This paper reports the psychometric properties and
diagnostic accuracy of the Luganda version of the nine-
item and two-item PHQ in a primary health care set-
ting in rural Uganda. Our results showed: (1) depres-
sion is a multi-faceted construct in this setting; and
(2) that the PHQ-9 has diagnostic utility in this setting;
(3) that the PHQ-2 did not perform well in this rural
population. However, a trade-oﬀ between high sensi-
tivity and low PPV must be noted.
The diagnostic characteristics of the PHQ-9
(AUROC = 0.74) and the PHQ-2 (AUROC = 0.68) indi-
cate that the PHQ-9 performance in the rural popula-
tion studied was modest. However, it could still be
used to screen for depression in primary care facilities
in rural Uganda. The PHQ-9 performed only slightly
better than the PHQ-2. The area under the receiver op-
erating characteristic curve in this study for both
PHQ-9 and PHQ-2 was smaller than that found in
similar settings in Ethiopia (PHQ-9, AUROC = 0.85
and PHQ-2, AUROC = 0.78) where the PHQ was
compared with a psychiatric nurse administered
MINI (Hanlon et al. 2015) and in South Africa
(PHQ-9, AUROC = 0.85 and PHQ-2, AUROC = 0.76)
where the PHQ was compared with clinical psycholo-
gist administered structured clinical interview for
DSM-IV (Bhana et al. 2015). The choice of MINI as a
gold standard, which has not been validated in
Uganda, could have led to the modest validity of the
Luganda PHQ-9 compared with that found in other
PHQ-9 validation studies in sub-Saharan Africa. Also
the local idioms of distress could have been diﬀerent
from the items in the PHQ-9 leading to lower validity
than would have been expected. For example Item no.
1 (little interest or pleasure in doing things) is often not
understood and is diﬃcult to translate to Luganda
for one to understand. Item no. 2 (feeling down,
depressed or hopeless) is often expressed as one ‘having
thoughts’ (Okello & Ekblad, 2006), which is a cognitive
construct rather than feeling sad which is an emotional
construct. This item therefore may not be understood
the same way or responded to appropriately in its cur-
rent form on the PHQ-9.
We suggest a potential cut-oﬀ score of ≧5 although
we note that at this there is a signiﬁcant trade-oﬀ be-
tween sensitivity and low PPV. The cut-oﬀ is similar
to that obtained in Nigeria among University students
where the PHQ-9 was validated against the MINI
(Adewuya et al. 2006). This cut-oﬀ is, however, lower
than what was recommend by other studies done
both in sub-Saharan Africa (Omoro et al. 2006) and glo-
bally (Manea et al. 2012). In a previous meta-analysis of
18 studies, Manea et al. (2012) found that the PHQ-9
performed well at cut-oﬀ scores between 8 and 11,
Fig. 2. Receiver operating curve for PHQ-9 and PHQ-2 for
adults in primary health care facilities in Kamuli, Uganda,
2014.
Table 1. Diagnostic characteristics of the PHQ-9 and PHQ-2 for
major depression among adults in primary care facilities in Kamuli
District, Uganda, 2014
PHQ-9 PHQ-2
SENS SPECI PPV SENS SPECI
≥0 100.0 0.0 26.2 100.0 0.0
≥1 85.8 25.2 29.0 66.2 58.9
≥2 85.8 45.4 35.8 38.9 91.4
≥3 78.7 57.9 40.0 16.5 94.3
≥4 67.4 66.0 41.3 5.4 98.9
≥5 67.4 78.1 52.3 1.1 99.7
≥6 44.6 88.2 57.4 0.8 99.7
≥7 27.6 94.3 63.3
≥8 27.6 96.3 72.7
≥9 22.2 97.0 72.5
≥10 14.9 98.4 76.5
≥11 10.3 98.8 75.0
≥12 8.8 99.3 82.1
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though only one of these studies was from
sub-Saharan Africa. Therefore, as proposed by Patel
et al. (2008), we recommend that the choice of an opti-
mal cut-oﬀ score based on the best balance between
sensitivity and PPV may need to be tailored to individ-
ual settings and purpose. This is particularly important
for routine use in low-income countries where the bur-
den on healthcare staﬀ is high (Kagee et al. 2013) and
referral of negative cases may put additional strain
on an already struggling health system.
The presence of two to three factors on the factor
analysis provides evidence that depression is a multi-
faceted construct in this setting. Several other studies
of the psychometric properties of the PHQ-9 found
the somatic and non-somatic symptoms of depression
loading onto diﬀerent factors (Richardson &
Richards, 2008; Kalpakjian et al. 2009; Chilcot et al.
2013; Zhong et al. 2014; Petersen et al. 2015).
Interpretation of these ﬁndings is further complicated
by the relatively high prevalence of somatic symptoms
reported by adults recruited from primary care facil-
ities, and those symptoms’ conﬂation with depressive
symptoms. While clinicians must take care to conﬁrm
that a high screening score is not an artefact of some
other underlying disorder, they must also be sensitized
to the non-speciﬁc manifestation of depressive symp-
toms and the likelihood of mis-diagnosis or under-
diagnosis. In particular item no. 1 (little interest or pleas-
ure in doing things) and item no. 4 (feeling tired or having
little energy) of the PHQ-9 were poorly correlated with
the total PHQ-9 score and both loaded on to the same
factor. These items are strong candidates for further
evaluation as to whether they are able to distinguish
between depressive and non-depressive symptoms in
an outpatient population and whether their translation
captures the correct idiom of distress.
This is the ﬁrst study to validate the PHQ-9 and
PHQ-2 in a Ugandan primary health care population.
A previous validation study had been done in a highly
selected HIV population (Akena et al. 2013). However,
the strengths notwithstanding, there were some limita-
tions. Firstly, the ﬁndings from this study may not be
generalizable to non-Luganda speakers or to popula-
tions outside health facilities. Secondly, there was sub-
stantial loss to follow up among participants who were
referred for the MINI diagnostic assessment. Both the
estimates of prevalence and the AUROC could be
biased by this loss to follow up. Lastly, because the
MINI administration was dependent on the PHQ-9
score, the MINI interview had to be conducted after
the PHQ-9. It is possible that the PHQ-9 primed parti-
cipants into being more open to discuss their depres-
sive symptoms during the diagnostic interview,
which would bias the AUROC estimates downward.
However, given that mental health services were not
yet available in this district, the participants remained
‘blind’ to their depression status, which is a source of
bias common in other validation studies of depression
screening tools (Thombs et al. 2011).
Conclusion
The Luganda translation of the PHQ-9 was found to
have modest validity in detecting depression. In clinics
where staﬀ have limited time, one would hope that the
PHQ-2 could be a useful alternative. However, in this
study, the PHQ-9 performed slightly better than the
PHQ-2. If one chose to screen with the PHQ-2 therefore,
onewould need to follow it upwith amore detailed tool
in order to accurately discriminate between those with
depression and thosewithout. Future research could im-
prove on diagnostic accuracy by considering the factor
structure of the LugandaPHQ-9, considering the idioms
of distress among Luganda speakers, and revising the
PHQ-9 accordingly.
Supplementary material
The supplementary material for this article can be
found at http://dx.doi.org/10.1017/gmh.2016.14.
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